• Profile
Close

Systemic lupus erythematosus and antiphospholipid antibody syndrome as risk factors for acute coronary syndrome in young patients: analysis of the national inpatient sample

MDlinx Mar 30, 2022

Introduction

Although traditional cardiovascular (CV) risk factors for ACS have been established for patients < 40 and > 40 years of age, the effect of secondary diagnoses with SLE and APLS on CV risk, if any, is not known.

Why This Study Matters

CV risk factors, whether traditional or non-traditional, can often be mitigated with a corresponding decrease in ACS risk.  The purpose of the current study was to determine the effect of two autoimmune rheumatic diseases (SLE and APLS) on ACS risk.

 

Study Design

The National Inpatient Sample database (2016-2018) served as the source for data in this study.  Eligible patients were adults who were hospitalized due to ACS as the primary diagnosis, with or without SLE or APLS as a secondary diagnosis.  The patients were grouped according to age as follows:  < 40 years; and > 40 years.  The primary outcome was ACS.

Results and Conclusions

Based on the National Inpatient Sample database (2016-2018), a total of 55,050 and 1,966,234 patients < 40 and > 40 years of age, respectively, were hospitalized with a primary diagnosis of ACS. Both groups of patients had traditional CV risk factors for ACS.  Among the patients < 40 years of age, SLE (OR = 2.18) and APLS (OR = 2.18) were strong risk factors for ACS.  Among the patients > 40 years of age, secondary diagnoses with SLE or APLS were not independently associated with risk for ACS.

Related Research

Consider the findings from a similar research study:

Original Source

Whittier M, Bautista Sanchez R, Arora S, et al. Systemic lupus erythematosus and antiphospholipid antibody syndrome as risk factors for acute coronary syndrome in young patients. Analysis of the National Inpatient Sample. J Clin Rheum 2022;28:143-6.

 

 

 

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay